Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-Bromo-3-methoxypropane is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

36865-41-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 36865-41-5 Structure
  • Basic information

    1. Product Name: 1-Bromo-3-methoxypropane
    2. Synonyms: 3-METHOXYPROPYLBROMIDE;1-BROMO-3-METHOXYPROPANE;1-BROMO-3-METHOXYPROPANE 99%;3-BROMO-1-METHOXYPROPANE;3-Bromopropyl methyl ether;1-Bromo-3-methoxypropane ,98%;1-broMo-3-Methoxyproane;1-BroMo-3-Methoxypro
    3. CAS NO:36865-41-5
    4. Molecular Formula: C4H9BrO
    5. Molecular Weight: 153.02
    6. EINECS: N/A
    7. Product Categories: Halides;Brinzolamide
    8. Mol File: 36865-41-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 132°C
    3. Flash Point: 30.6 °C
    4. Appearance: /
    5. Density: 1.36 g/cm3
    6. Vapor Pressure: 37.2mmHg at 25°C
    7. Refractive Index: 1.4450-1.4490
    8. Storage Temp.: Store below +30°C.
    9. Solubility: N/A
    10. CAS DataBase Reference: 1-Bromo-3-methoxypropane(CAS DataBase Reference)
    11. NIST Chemistry Reference: 1-Bromo-3-methoxypropane(36865-41-5)
    12. EPA Substance Registry System: 1-Bromo-3-methoxypropane(36865-41-5)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36/37/39
    4. RIDADR: 2344
    5. WGK Germany:
    6. RTECS:
    7. HazardClass: IRRITANT
    8. PackingGroup:
    9. Hazardous Substances Data: 36865-41-5(Hazardous Substances Data)

36865-41-5 Usage

Chemical Properties

Colorless liquid

Check Digit Verification of cas no

The CAS Registry Mumber 36865-41-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,8,6 and 5 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 36865-41:
(7*3)+(6*6)+(5*8)+(4*6)+(3*5)+(2*4)+(1*1)=145
145 % 10 = 5
So 36865-41-5 is a valid CAS Registry Number.
InChI:InChI=1/C4H9BrO/c1-6-4-2-3-5/h2-4H2,1H3

36865-41-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Bromo-3-methoxypropane

1.2 Other means of identification

Product number -
Other names 1-bromo-3-methoxypropane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:36865-41-5 SDS

36865-41-5Synthetic route

trimethoxonium tetrafluoroborate
420-37-1

trimethoxonium tetrafluoroborate

1-bromo-3-propanol
627-18-9

1-bromo-3-propanol

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

Conditions
ConditionsYield
In dichloromethane 1.) reflux, 2.) K2CO3, water;58%
methoxypropanol
1589-49-7

methoxypropanol

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

Conditions
ConditionsYield
With N-Bromosuccinimide; triphenylphosphine at 25℃; for 16h;51%
With bromine; triphenylphosphine In pyridine; dichloromethane for 2h;50%
With phosphorus tribromide for 2h; Ambient temperature;40%
1-bromo-3-propanol
627-18-9

1-bromo-3-propanol

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In diethyl ether at -10℃;22%
With H(+)-zeolite-X In benzene at 25℃; for 0.5h;89 % Chromat.
methanol
67-56-1

methanol

1,3-dibromo-propane
109-64-8

1,3-dibromo-propane

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

Conditions
ConditionsYield
With zinc(II) oxide at 100℃;
sodium methylate
124-41-4

sodium methylate

1,3-dibromo-propane
109-64-8

1,3-dibromo-propane

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

Conditions
ConditionsYield
With methanol
With methanol
6-bromo-2-(3,4-difluorophenyl)-4H-benzo[1,4]oxazin-3-one

6-bromo-2-(3,4-difluorophenyl)-4H-benzo[1,4]oxazin-3-one

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

C18H16BrF2NO3
949008-25-7

C18H16BrF2NO3

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 16h; Heating;100%
6-bromo-2-(4-fluorophenyl)-4H-benzo[1,4]oxazin-3-one

6-bromo-2-(4-fluorophenyl)-4H-benzo[1,4]oxazin-3-one

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

C18H17BrFNO3

C18H17BrFNO3

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 14h; Heating;100%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

3-methoxy-1-propanesulfonyl chloride
64297-55-8

3-methoxy-1-propanesulfonyl chloride

Conditions
ConditionsYield
Stage #1: 3-bromopropanol methyl ether With sodium sulfite In water for 24h; Heating / reflux;
Stage #2: With trichlorophosphate at 80 - 100℃; for 7h;
100%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

meta-nitrophenol
554-84-7

meta-nitrophenol

1-(3-methoxypropoxy)-3-nitrobenzene
1041399-44-3

1-(3-methoxypropoxy)-3-nitrobenzene

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 90℃;100%
Stage #1: meta-nitrophenol With sodium hydride In N,N-dimethyl-formamide for 0.166667h;
Stage #2: 3-bromopropanol methyl ether In N,N-dimethyl-formamide at 20℃; for 18.0833h;
83%
isovanillin
621-59-0

isovanillin

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

4-methoxy-3-(3-methoxypropoxy)benzaldehyde
172900-75-3

4-methoxy-3-(3-methoxypropoxy)benzaldehyde

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 3h; Reflux;100%
With N-benzyl-N,N,N-triethylammonium chloride; potassium carbonate In acetonitrile Reflux;100%
With potassium carbonate In acetonitrile95%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

N-(2-(1,1-dioxido-4-thiomorpholinyl)ethyl)-2-nitrobenzenesulfonamide
1392314-22-5

N-(2-(1,1-dioxido-4-thiomorpholinyl)ethyl)-2-nitrobenzenesulfonamide

N-(2-(1,1-dioxido-4-thiomorpholinyl)ethyl)-N-(3-methoxypropyl)-2-nitrobenzenesulfonamide
1392314-27-0

N-(2-(1,1-dioxido-4-thiomorpholinyl)ethyl)-N-(3-methoxypropyl)-2-nitrobenzenesulfonamide

Conditions
ConditionsYield
Stage #1: N-(2-(1,1-dioxido-4-thiomorpholinyl)ethyl)-2-nitrobenzenesulfonamide With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: 3-bromopropanol methyl ether With caesium carbonate In N,N-dimethyl-formamide at 20 - 70℃; for 73h;
100%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

methyl 1-(5-chloro-2-hydroxybenzyl)-1H-indole-4-carboxylate
1428130-30-6

methyl 1-(5-chloro-2-hydroxybenzyl)-1H-indole-4-carboxylate

C21H22ClNO4

C21H22ClNO4

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 60℃;100%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

ethyl 9'-hydroxy-10'-methoxy-2'-oxo-2',7'-dihydrospiro[cyclopentane-1,6'-pyrido[2,1-a]isoquinoline]-3'-carboxylate

ethyl 9'-hydroxy-10'-methoxy-2'-oxo-2',7'-dihydrospiro[cyclopentane-1,6'-pyrido[2,1-a]isoquinoline]-3'-carboxylate

ethyl 10'-methoxy-9'-(3-methoxypropoxy)-2'-oxo-2',7'-dihydrospiro[cyclopentane-1,6'-pyrido[2,1-a]isoquinoline]-3'-carboxylate

ethyl 10'-methoxy-9'-(3-methoxypropoxy)-2'-oxo-2',7'-dihydrospiro[cyclopentane-1,6'-pyrido[2,1-a]isoquinoline]-3'-carboxylate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;100%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

(S)-tert-butyl (1-(6-chloro-5-hydroxy-2-iodopyridin-3-yl)-3,3-dimethylbutan-2-yl)carbamate

(S)-tert-butyl (1-(6-chloro-5-hydroxy-2-iodopyridin-3-yl)-3,3-dimethylbutan-2-yl)carbamate

tert-butyl (S)-(1-(6-chloro-2-iodo-5-(3-methoxypropoxy)pyridin-3-yl)-3,3-dimethylbutan-2-yl)carbamate

tert-butyl (S)-(1-(6-chloro-2-iodo-5-(3-methoxypropoxy)pyridin-3-yl)-3,3-dimethylbutan-2-yl)carbamate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 3h;100%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

5-bromo-2-iodo-phenol
858855-11-5

5-bromo-2-iodo-phenol

4-bromo-1-iodo-2-(3-methoxypropoxy)benzene

4-bromo-1-iodo-2-(3-methoxypropoxy)benzene

Conditions
ConditionsYield
With potassium carbonate In water; ethyl acetate; N,N-dimethyl-formamide99.9%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

5-bromo-2-chlorophenol
183802-98-4

5-bromo-2-chlorophenol

4-bromo-1-chloro-2-(3-methoxypropoxy)benzene
897954-59-5

4-bromo-1-chloro-2-(3-methoxypropoxy)benzene

Conditions
ConditionsYield
With potassium carbonate In acetone at 50℃; for 15h; Solvent;99.44%
With potassium carbonate In N,N-dimethyl-formamide at 50℃; for 16h;91%
With potassium carbonate at 20℃; for 16h;89.1%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

4-bromo-2-Hydroxybenzoic Acid Methylester
22717-56-2

4-bromo-2-Hydroxybenzoic Acid Methylester

methyl 4-bromo-2-(3-methoxypropoxy)benzoate
1399849-96-7

methyl 4-bromo-2-(3-methoxypropoxy)benzoate

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 80℃; for 12h; Temperature;99.3%
With potassium carbonate In acetonitrile at 80℃; for 12h;99.3%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

5-bromo-2-methoxyphenol
37942-01-1

5-bromo-2-methoxyphenol

4-bromo-1-methoxy-2-(3-methoxypropoxy)benzene
173336-76-0

4-bromo-1-methoxy-2-(3-methoxypropoxy)benzene

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetonitrile for 24h; Reflux;99%
With potassium carbonate In N,N-dimethyl-formamide at 25℃; for 8h;99.12%
With potassium carbonate In N,N-dimethyl-formamide99%
2-pyrrole aldehyde
1003-29-8

2-pyrrole aldehyde

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

1-(3-methoxypropyl)-1H-pyrrole-2-carbaldehyde
869106-75-2

1-(3-methoxypropyl)-1H-pyrrole-2-carbaldehyde

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 20℃; for 16h;99%
With sodium hydride In tetrahydrofuran for 4.25h; Inert atmosphere;60%
4-carbethoxypiperidine
1126-09-6

4-carbethoxypiperidine

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

ethyl 1-(3-methoxy-propyl)-piperidin-4-carboxylate
1249604-45-2

ethyl 1-(3-methoxy-propyl)-piperidin-4-carboxylate

Conditions
ConditionsYield
With caesium carbonate In acetonitrile for 4h; Reflux;99%
With caesium carbonate In acetonitrile for 4h; Reflux;99%
With potassium carbonate In acetonitrile at 25 - 85℃; for 7.5h; Inert atmosphere; Reflux; Large scale;98.8%
With potassium carbonate In acetonitrile for 7.25h; Reflux;90%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

4'-bromo-2'-hydroxyacetophenone
30186-18-6

4'-bromo-2'-hydroxyacetophenone

1-(4-bromo-2-(3-methoxypropoxy)phenyl)ethanone
905831-23-4

1-(4-bromo-2-(3-methoxypropoxy)phenyl)ethanone

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;99%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

5-bromo-2-nitrophenol
27684-84-0

5-bromo-2-nitrophenol

4-bromo-2-(3-methoxypropoxy)-1-nitrobenzene

4-bromo-2-(3-methoxypropoxy)-1-nitrobenzene

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 50℃;99%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

N-(4-bromo-2-methoxyphenyl)acetamide
143360-01-4

N-(4-bromo-2-methoxyphenyl)acetamide

N-(4-bromo-2-methoxyphenyl)-N-(3-methoxypropyl)acetamide

N-(4-bromo-2-methoxyphenyl)-N-(3-methoxypropyl)acetamide

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 12h;99%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

2-(benzyloxy)-5-bromophenol
153241-03-3

2-(benzyloxy)-5-bromophenol

1-(benzyloxy)-4-bromo-2-(3-methoxypropoxy)benzene

1-(benzyloxy)-4-bromo-2-(3-methoxypropoxy)benzene

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 50℃;98.1%
With potassium carbonate In N,N-dimethyl-formamide at 50℃; for 12h;98.1%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

triphenylphosphine
603-35-0

triphenylphosphine

(3-methoxypropyl)(triphenyl)phosphonium bromide
111088-69-8

(3-methoxypropyl)(triphenyl)phosphonium bromide

Conditions
ConditionsYield
In toluene at 150℃; for 44h;98%
In toluene at 150℃; for 24h;96.9%
In toluene at 150℃; for 16h; Inert atmosphere;91%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

tert-butyl isopropylidenecarbazate
16689-34-2

tert-butyl isopropylidenecarbazate

N’isopropylidene-N-(3-methoxy-propyl)-hydrazinecarboxylic acid tert-butyl ester
950859-79-7

N’isopropylidene-N-(3-methoxy-propyl)-hydrazinecarboxylic acid tert-butyl ester

Conditions
ConditionsYield
With potassium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In toluene at 50 - 80℃; for 3.75h;98%
With tetra-(n-butyl)ammonium iodide; potassium hydroxide at 60℃;70%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

C13H14N2O5
1251583-07-9

C13H14N2O5

C17H22N2O6
1251583-09-1

C17H22N2O6

Conditions
ConditionsYield
Stage #1: C13H14N2O5 With caesium carbonate In dimethyl sulfoxide for 0.0833333h;
Stage #2: 3-bromopropanol methyl ether In dimethyl sulfoxide at 20℃; for 18h;
98%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

methyl 2-(2-(4-hydroxyphenyl)thiazol-4-yl)-2-methylpropanoate

methyl 2-(2-(4-hydroxyphenyl)thiazol-4-yl)-2-methylpropanoate

methyl 2-(2-(4-(3-methoxypropoxy)phenyl)thiazol-4-yl)-2-methylpropanoate

methyl 2-(2-(4-(3-methoxypropoxy)phenyl)thiazol-4-yl)-2-methylpropanoate

Conditions
ConditionsYield
With potassium carbonate In acetone Reflux;98%
With potassium carbonate In acetone Reflux;98%
With potassium carbonate In acetone Reflux;98%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

6-(4-bromophenyl)-4,4-dimethyl-4,5-dihydropyridazin-3(2H)-one

6-(4-bromophenyl)-4,4-dimethyl-4,5-dihydropyridazin-3(2H)-one

6-(4-bromophenyl)-2-(3-methoxypropyl)-4,4-dimethyl-4,5-dihydropyridazin-3(2H)-one

6-(4-bromophenyl)-2-(3-methoxypropyl)-4,4-dimethyl-4,5-dihydropyridazin-3(2H)-one

Conditions
ConditionsYield
Stage #1: 6-(4-bromophenyl)-4,4-dimethyl-4,5-dihydropyridazin-3(2H)-one With sodium hydride In tetrahydrofuran at 0℃; for 0.5h;
Stage #2: 3-bromopropanol methyl ether In tetrahydrofuran at 20℃;
98%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

C13H13BrN2O5
1251582-90-7

C13H13BrN2O5

C17H21BrN2O6
1251582-98-5

C17H21BrN2O6

Conditions
ConditionsYield
Stage #1: C13H13BrN2O5 With caesium carbonate In dimethyl sulfoxide for 0.0833333h;
Stage #2: 3-bromopropanol methyl ether In dimethyl sulfoxide at 20℃; for 18h;
97%
7-(benzyloxy)-1,2,3,4-tetrahydroquinoline

7-(benzyloxy)-1,2,3,4-tetrahydroquinoline

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

C20H25NO2
943937-28-8

C20H25NO2

Conditions
ConditionsYield
With sodium carbonate; potassium iodide In acetonitrile for 74h; Heating;96%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

C18H13BrClNO4
1251582-45-2

C18H13BrClNO4

C22H21BrClNO5
1251584-49-2

C22H21BrClNO5

Conditions
ConditionsYield
With caesium carbonate In dimethyl sulfoxide at 50℃; for 2h;96%
With caesium carbonate In dimethyl sulfoxide at 20℃; for 2h; Inert atmosphere;64%
4-bromo-1H-pyrazole
2075-45-8

4-bromo-1H-pyrazole

3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

4-bromo-1-(3-methoxypropyl)-1H-pyrazole
1183903-41-4

4-bromo-1-(3-methoxypropyl)-1H-pyrazole

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide at 50℃;96%
With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 8h;94%
With caesium carbonate In N,N-dimethyl-formamide at 50℃;
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

(R)-tert-butyl 3-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate
1234709-86-4

(R)-tert-butyl 3-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate

(R)-tert-butyl 3-(1-(3-methoxypropyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate
1365884-41-8

(R)-tert-butyl 3-(1-(3-methoxypropyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: (R)-tert-butyl 3-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5h; Inert atmosphere;
Stage #2: 3-bromopropanol methyl ether In N,N-dimethyl-formamide; mineral oil at 0 - 20℃;
96%
3-bromopropanol methyl ether
36865-41-5

3-bromopropanol methyl ether

5-[(2S,3S)-1-tert-butoxycarbonyl-3-phenylpyrrolidine-2-carboxamide]-1H-indole-2-carboxylic acid

5-[(2S,3S)-1-tert-butoxycarbonyl-3-phenylpyrrolidine-2-carboxamide]-1H-indole-2-carboxylic acid

3-methoxypropyl 5-[(2S,3S)-1-tert-butoxycarbonyl-3-phenylpyrrolidine-2-carboxamide]-1H-indole-2-carboxylate

3-methoxypropyl 5-[(2S,3S)-1-tert-butoxycarbonyl-3-phenylpyrrolidine-2-carboxamide]-1H-indole-2-carboxylate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;96%

36865-41-5Relevant articles and documents

NPY ANTAGONISTS, PREPARATION AND USES

-

Page/Page column 98, (2009/09/28)

The present invention concerns novel compounds, their preparation and their uses, therapeutic uses in particular. More specifically it concerns derivative compounds having at least two aromatic cycles, their preparation and their uses, in particular in the area of human or animal health. These compounds have an affinity for the biological receptors of neuropeptide Y, NPY, present in the central and peripheral nervous systems. The compounds of the invention are preferably NPY antagonists, and more particularly antagonists of sub-type NPY Y1, and can therefore be used for the therapeutic or prophylactic treatment of any disorder involving NPY. The present invention also concerns pharmaceutical compositions containing said compounds, their preparation and their uses, as well as treatment methods using said compounds.

Indole derivatives as 5-HT1-like agonists

-

, (2008/06/13)

Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 is a substituted alkylene; C3 -C7 cycloalkyl optionally substituted with HO; C3 -C6 alkenyl optionally substituted with aryl; C5 -C7 cycloalkenyl; or C3 -C6 alkynyl; R2 is H; halo; F3 C; NC; R8 R9 NOC; a substituted alkylene; R8 R9 NO2 S; R10 S(O)m ; R12 CON(R11); R10 SO2 N(R11); R8 R9 NOCN(R11); R10 O2 CN(R11); R13 (CH2)n CH=CH; or R7 O are selective 5-HT1 -like receptor agonists useful in the treatment of migraine, cluster headache, chronic paroxysmal hemicrania and headache associated with vascular disorders.

A New Oxaanalog of Myristic Acid that Suppresses Replication of Human Immunodeficiency Virus

Vodovozova, E. L.,Mikhalev, I. I.,Rzhaninova, A. A.,Garaev, M. M.,Molotkovsky, Yul. G.

, p. 626 - 632 (2007/10/03)

A series of oxaanalogs of myristic acid were synthesized and tested for antiviral activity in MT4 cells infected with human immunodeficiency virus 1 (HIV-1).The synthesized acids have no toxic effect on uninfected MT4 cells at a concentration of 100μM. 14,14,14-Trifluoro-12-oxatetradecanoic acid substantially (by 75percent) inhibits the reproduction of HIV-1.Other compounds synthesized, (7Z)-13-, (9Z)-13-, and (7Z)-11-oxatetradecenoic acids, exhibit no antiviral effect.Key words: inhibitors of retroviruses; anti-HIV agents; protein N-myristoylation; mystoylCoA: protein-N-myristoyltransferase; myristic acid; oxaanalogs; inhibitors of virus-specific protein myristoylation

EFFICIENT AND/OR SELECTIVE METHYLATION BY DIAZOMETHANE OF ALCOHOLS, HALO ALCOHOLS, GLYCOLS, AMINO ALCOHOLS AND MERCAPTO ALCOHOLS WITH THE USE OF A PROTON-EXCHANGED X-TYPE ZEOLITE AS AN ACID-BASE BIFUNCTIONAL CATALYST

Takeuchi, Hiroshi,Kishioka, Hiroaki,Kitajima, Kunio

, p. 121 - 126 (2007/10/02)

Reactions of diazomethane with butanol, allyl alcohol and β- and γ-halo alcohols led to efficient methylation (giving the corresponding methyl ethers) with the use of a proton-excahnged X-type zeolite compared with H2SO4.The reactions with propylene and isobutylene glycols using the zeolite provided regioselective methylation of the primary OH rather than the secondary or tertiary OH, whereas regioselectivity was not observed in the reactions using H2SO4.The reactions with 2-aminoethanol and 2-mercaptoethanol showed high chemoselective S-methylation and N-monomethylation, respectively, in the presence of the zeolite instead of H2SO4.The mechanism for the reactions is proposed to involve acid-base bifunctional catalysis of the zeolite in which the acidic site reacts with diazomethane to form its conjugate acid, and the nucleophilicity of OH and SH groups is enhanced by the interaction of the basic site with the proton of the groups.

X-Ray structure of tetrameric 1-lithio-3-methoxypropane

Klumpp, G. W.,Geurink, P. J. A.,Hommes, N. J. R. van Eikema,Kanter, F. J. J. de,Vos, M.,Spek, A. L.

, p. 398 - 403 (2007/10/02)

The crystal structure of (LiCH2CH2CH2OMe)4 consists of a distorted (CH2)4Li4 cube, four parallel edges of which are spanned by CH2CH2Ome chains.The interatomicdistances provide insights into the nature of alkyllithium-Lewis base (ethers, tertiary amines) interactions and into the structural basis of the differential reactivity and stability of primary and secondary alkyllithium tetramers.NMR of hydrocarbon solutions indicates that under these conditions the solid state tetramer is in equilibrium with a stereoisomer.

Hydrogen Bonds involving Polar CH Groups. Part 9. Optimum Structural Parameters, and Unequivocal Demonstration of such Intramolecular Interactions in 2-Substituted 1,3-Dithian 1,1,3,3-Tetraoxides

Li, Chuen,Sammes, Michael P.

, p. 1303 - 1310 (2007/10/02)

A series of 2-monosubstituted 1,3-dithian 1,1,3,3-tetraoxides have been prepared, having side chains with 2-6 carbon atoms, and bearing alkyl, aryl, methoxy, dialkylamino, and pyridyl terminal substituents, as models for intramolecular C-H...X hydrogen bonds.Methoxy- and amino-substituents, in compounds having two or three carbon atoms in the side chain, show significant intramolecular interaction with the disulphone methine hydrogen in dichloromethane, as evidenced by a downfield shift of the 1H n.m.r. signals; shifts of up to 2.0 p.p.m. have been observed.Intramolecular H-bonds are disrupted in acetone and in pyridine owing to competing intermolecular interactions with the solvents, and in trifluoroacetic acid owing to protonation of the donor atom.

Total Synthesis of Lycopodium Alkaloids: (+/-)-Lycopodine, (+/-)-Lycodine, and (+/-)-Lycodoline

Heathcock, Clayton H.,Kleinman, Edward F.,Binkley, Edward S.

, p. 1054 - 1068 (2007/10/02)

Intramolecular Mannich condensation is shown to be a powerful method for the synthesis of lycopodium alkaloids (eq 2).Two syntheses of (+/-)-lycopodine (1) have been developed.In the first (Scheme II), compound 1 is produced in 13 steps from 5-methyl-1,3-cyclohexanedione (16.6percent overall yield).In this synthesis, rings A and B are formed in the Mannich cyclization, and ring D is closed by aldol condensation.The alternative lycopodine synthesis (Scheme IV) is more convergent and produces (+/-)-1 in only eight operations from the same starting point (13percent overall yield).In this synthesis, primary amine 41 is employed in the Mannich reaction, and ring D is closed by intramolecular alkylation or a bromo amine.The synthesis of (+/-)-lycodine (3) also requires eight steps and provides the alkaloid in 13.2percent overall yield (Scheme V).This synthesis features an efficient, one-pot conversion of δ,ε-unsaturated ketone 46 into pyridine 3. (+/-)-Lycodoline (3) is produced by an 11-step route in 3.2percent overall yield as shown in eq 16, 18, and 22.In this synthesis, the angular hydroxyl is introduced by the stereoselective autoxidation of an octahydroquinone (eq.16).The Mannich cyclization is completed by a novel method which utilizes the base-catalyzed polymerization of 3-bromo-1-propanol as a method for slow delivery of HBr, thus allowing the reaction to be carried out under essentially neutral conditions (eq.18).The lycodoline synthesis is completed by use of a novel variant of the Oppenauer oxidation (61 -> 62).

THIONE PHOTOCHEMISTRY. DUAL PATHWAYS IN ARALKYL THIONE CYCLIZATIONS

Basu, S.,Couture, Axel,Ho, Kam W.,Hoshino, Mikio,Mayo, Paul De,Suau, R.

, p. 246 - 254 (2007/10/02)

It is shown that aralkyl thiones, which posses an oxygen atom at the δ position in the side chain, can therefore not undergo the preferred δ insertion, and insert at the γ and ε positions.Although ε insertion occurs only from the 1(Π,Π*) state, γ abstraction ( followed by cyclization or cleavage ) occurs from both 1(Π,Π*) and 3(n,Π*) states.The quantum yields of photocyclization of 2c, 2d, and 2g change little with solvent polarity, which suggest that a thione-ether charge transfer interaction contributes little to the cyclization.Fluorescence and product quenching studies are reported which support this.

Polar Substituent Effects in the Solvolysis of Primary and Tertiary Alkyl Halides. Polar Effect IX

Grob, Cyril A.,Waldner, Adrian

, p. 2152 - 2158 (2007/10/02)

When the Hammett-Taft equation log (k/k0) = ρq ?qi is applied to the solvolysis of the 3-substituted propyl bromides 6a-6i in ethanol/water 4:1 (v/v) log k correlates linearly with ?qI except in cases where R exerts an anchimetric effect.The reaction constant ρq for 6 is -0.12 and is typical for a nucleophilic solvent assisted ks process at a primary C-atom.The tertiary halides 1 and 3, however, which reacty with little or no nucleophilic solvent assistance, i.e. by kc processes, lead to larger ρq values of -0.71 and -1.14, respectively.The reacton constant ρq is therefore a sensitive gauge for charge development in the transition state for solvolysis of satured compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 36865-41-5